cefprozil

Generic: cefprozil

Labeler: lupin pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cefprozil
Generic Name cefprozil
Labeler lupin pharmaceuticals, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

cefprozil 250 mg/5mL

Manufacturer
Lupin Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68180-402
Product ID 68180-402_45d1a412-407b-48d4-be64-b9c7ec3c5205
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065261
Listing Expiration 2026-12-31
Marketing Start 2005-12-01

Pharmacologic Class

Established (EPC)
cephalosporin antibacterial [epc]
Chemical Structure
cephalosporins [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68180402
Hyphenated Format 68180-402

Supplemental Identifiers

RxCUI
309080 309081
UPC
0368180401032 0368180402039
UNII
4W0459ZA4V
NUI
N0000175488 M0003827

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cefprozil (source: ndc)
Generic Name cefprozil (source: ndc)
Application Number ANDA065261 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/5mL
source: ndc
Packaging
  • 50 mL in 1 BOTTLE (68180-402-01)
  • 75 mL in 1 BOTTLE (68180-402-02)
  • 100 mL in 1 BOTTLE (68180-402-03)
source: ndc

Packages (3)

Ingredients (1)

cefprozil (250 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45d1a412-407b-48d4-be64-b9c7ec3c5205", "openfda": {"nui": ["N0000175488", "M0003827"], "upc": ["0368180401032", "0368180402039"], "unii": ["4W0459ZA4V"], "rxcui": ["309080", "309081"], "spl_set_id": ["3ec55c0a-1456-412e-972f-352b3135c8f2"], "pharm_class_cs": ["Cephalosporins [CS]"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE (68180-402-01)", "package_ndc": "68180-402-01", "marketing_start_date": "20051201"}, {"sample": false, "description": "75 mL in 1 BOTTLE (68180-402-02)", "package_ndc": "68180-402-02", "marketing_start_date": "20051201"}, {"sample": false, "description": "100 mL in 1 BOTTLE (68180-402-03)", "package_ndc": "68180-402-03", "marketing_start_date": "20051201"}], "brand_name": "CEFPROZIL", "product_id": "68180-402_45d1a412-407b-48d4-be64-b9c7ec3c5205", "dosage_form": "POWDER, FOR SUSPENSION", "product_ndc": "68180-402", "generic_name": "CEFPROZIL", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CEFPROZIL", "active_ingredients": [{"name": "CEFPROZIL", "strength": "250 mg/5mL"}], "application_number": "ANDA065261", "marketing_category": "ANDA", "marketing_start_date": "20051201", "listing_expiration_date": "20261231"}